MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Third Quarter 2025 Operating and Financial Results Conference Call.
Mimedx Group Inc. (MDXG)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Trigran Investments Douglas T. Granat | 7,701,028 | $53,753,176 | -9% | 9.74% |
| 2. | Cannell Capital J. Carlo Cannell | 2,013,840 | $14,056,603 | -3% | 2.14% |
| 3. | Renaissance Technologies Jim Simons | 2,008,227 | $14,017,424 | -5% | 0.02% |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,466,566 | $10,236,631 | 0.36% | |
| 5. | Meros Investment Management Timothy Chatard | 1,270,357 | $8,867,092 | +19% | 3.79% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.34 | 200,000 | $1,268,000.00 | 529,530 | 2025-05-02 | Filing | |
| $7.16 | 5,000 | $35,786.50 | 102,200 | 2023-11-21 | Filing | |
| $6.50 | 42,025 | $273,330.60 | 100,000 | 2023-06-23 | Filing | |
| $6.33 | 57,975 | $367,103.50 | 57,975 | 2023-06-22 | Filing | |
| $6.99 | 20,000 | $139,800.00 | 5,009,121 | 2016-05-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.42 | 58,300 | $432,329.48 | 236,982 | 2025-11-06 | Filing | |
| $8.04 | 1,759 | $14,142.36 | 309,077 | 2025-03-17 | Filing | |
| $7.89 | 20,366 | $160,687.74 | 440,178 | 2025-03-13 | Filing | |
| $7.89 | 34,230 | $270,074.70 | 460,544 | 2025-03-13 | Filing | |
| $7.89 | 4,106 | $32,396.34 | 310,836 | 2025-03-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 28,195,249 | $196,802,838 | 64.08% | |
| 2. | 11,322,460 | $79,030,770 | 0% | |
| 3. | 6,801,639 | $47,475,441 | 0% | |
| 4. | 3,652,952 | $25,497,605 | 2.4% | |
| 5. | 3,594,606 | $25,090,350 | 0% |
News See All
MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy
MiMedx Group, Inc. (NASDAQ:MDXG) is a biotechnology company based in Marietta, Georgia, specializing in regenerative biologics for advanced wound care and surgical recovery.
10 Best Biotech Stocks to Buy Under $10
The head biotech analyst at Goldman Sachs, Salveen Richter, appeared on CNBC's "Squawk Box" on July 25 to discuss various topics, including the current status of the biotech industry and what to expect...
MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Second Quarter 2025 Operating and Financial Results Conference Call.
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MIMEDX First Quarter 2025 Operating and Financial Results Conference Call.
MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Fourth Quarter and Full Year 2024 Operating Financial Results Conference Call.
MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Third Quarter 2024 Operating and Financial Results Conference Call.
MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to the MiMedx Second Quarter 2024 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only mode.
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript
MiMedx Group, Inc. beats earnings expectations. Reported EPS is $0.07, expectations were $0.04.
MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2023 Earnings Call Transcript
MiMedx Group, Inc. misses on earnings expectations. Reported EPS is $0.04 EPS, expectations were $0.08. MiMedx Group, Inc.